Clinical Trial Update: Trial of MSC1936369B in Subjects With Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial update for MSC1936369B in subjects with solid tumors (cancer) has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Solid Tumors

Drugs mentioned

• MSC1936369B (MSC1936369B)

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Solid Tumors, Cancer | Phase 1 | Status: COMPLETED | Results posted: 2018-10-23